Literature DB >> 21488895

Molecular mechanisms of T-cell tolerance.

Roza I Nurieva1, Xindong Liu, Chen Dong.   

Abstract

CD4(+) T cells are the master regulators of adaptive immune responses, and many autoimmune diseases arise due to a breakdown of self-tolerance in CD4(+) T cells. Activation of CD4(+) T cells is regulated by not only the binding of peptide-major histocompatibility complexes to T-cell receptor but also costimulatory signals from antigen-presenting cells. Recently, there has been progress in understanding the extracellular and intracellular mechanisms that are required for implementation and maintenance of T-cell tolerance. Understanding of the molecular mechanisms underlying T-cell tolerance will lead to development of pharmacological approaches either to promote the tolerance state in terms of autoimmunity or to break tolerance in cancer.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21488895      PMCID: PMC5131796          DOI: 10.1111/j.1600-065X.2011.01012.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  120 in total

1.  ICOS co-stimulatory receptor is essential for T-cell activation and function.

Authors:  C Dong; A E Juedes; U A Temann; S Shresta; J P Allison; N H Ruddle; R A Flavell
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

2.  Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity.

Authors:  Omid Akbari; Gordon J Freeman; Everett H Meyer; Edward A Greenfield; Tammy T Chang; Arlene H Sharpe; Gerald Berry; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  Nat Med       Date:  2002-07-29       Impact factor: 53.440

Review 3.  Costimulatory regulation of T cell function.

Authors:  C A Chambers; J P Allison
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

4.  The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice.

Authors:  W L Perry; C M Hustad; D A Swing; T N O'Sullivan; N A Jenkins; N G Copeland
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b.

Authors:  K Bachmaier; C Krawczyk; I Kozieradzki; Y Y Kong; T Sasaki; A Oliveira-dos-Santos; S Mariathasan; D Bouchard; A Wakeham; A Itie; J Le; P S Ohashi; I Sarosi; H Nishina; S Lipkowitz; J M Penninger
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

6.  Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.

Authors:  D Tzachanis; G J Freeman; N Hirano; A A van Puijenbroek; M W Delfs; A Berezovskaya; L M Nadler; V A Boussiotis
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

7.  Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells.

Authors:  Gang Wei; Lai Wei; Jinfang Zhu; Chongzhi Zang; Jane Hu-Li; Zhengju Yao; Kairong Cui; Yuka Kanno; Tae-Young Roh; Wendy T Watford; Dustin E Schones; Weiqun Peng; Hong-Wei Sun; William E Paul; John J O'Shea; Keji Zhao
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

8.  Recurrent superantigen exposure in vivo leads to highly suppressive CD4+CD25+ and CD4+CD25- T cells with anergic and suppressive genetic signatures.

Authors:  J M Schartner; A M Singh; P E Dahlberg; L Nettenstrom; C M Seroogy
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

9.  Transcriptional regulation of th2 differentiation by inducible costimulator.

Authors:  Roza I Nurieva; Julie Duong; Hiroko Kishikawa; Umberto Dianzani; Jose M Rojo; I cheng Ho; Richard A Flavell; Chen Dong
Journal:  Immunity       Date:  2003-06       Impact factor: 31.745

10.  Itch-/- alphabeta and gammadelta T cells independently contribute to autoimmunity in Itchy mice.

Authors:  Valentino Parravicini; Anne-Christine Field; Peter D Tomlinson; M Albert Basson; Rose Zamoyska
Journal:  Blood       Date:  2008-02-06       Impact factor: 22.113

View more
  36 in total

1.  Urate crystals directly activate the T-cell receptor complex and induce T-cell proliferation.

Authors:  Theodoros Eleftheriadis; Georgios Pissas; Maria Sounidaki; Georgia Antoniadi; Ioannis Tsialtas; Vassilios Liakopoulos; Ioannis Stefanidis
Journal:  Biomed Rep       Date:  2017-08-04

Review 2.  Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

Authors:  Yu Fujita; Roberto Tinoco; Yan Li; Daniela Senft; Ze'ev A Ronai
Journal:  Trends Mol Med       Date:  2019-03-18       Impact factor: 11.951

3.  Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial.

Authors:  Saby George; Robert J Motzer; Hans J Hammers; Bruce G Redman; Timothy M Kuzel; Scott S Tykodi; Elizabeth R Plimack; Joel Jiang; Ian M Waxman; Brian I Rini
Journal:  JAMA Oncol       Date:  2016-09-01       Impact factor: 31.777

4.  ORAI1 deficiency impairs activated T cell death and enhances T cell survival.

Authors:  Kyun-Do Kim; Sonal Srikanth; Ma-Khin Win Yee; Dennis C Mock; Gregory W Lawson; Yousang Gwack
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

5.  The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells.

Authors:  Gustavo J Martinez; Renata M Pereira; Tarmo Äijö; Edward Y Kim; Francesco Marangoni; Matthew E Pipkin; Susan Togher; Vigo Heissmeyer; Yi Chen Zhang; Shane Crotty; Edward D Lamperti; K Mark Ansel; Thorsten R Mempel; Harri Lähdesmäki; Patrick G Hogan; Anjana Rao
Journal:  Immunity       Date:  2015-02-10       Impact factor: 31.745

6.  Mechanisms and pathophysiology of autoimmune disease.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

7.  Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction.

Authors:  Xindong Liu; Yun Wang; Huiping Lu; Jing Li; Xiaowei Yan; Minglu Xiao; Jing Hao; Andrei Alekseev; Hiep Khong; Tenghui Chen; Rui Huang; Jin Wu; Qiwen Zhao; Qi Wu; Senlin Xu; Xiaohu Wang; Wei Jin; Shicang Yu; Yan Wang; Lai Wei; Aibo Wang; Bo Zhong; Ling Ni; Xiaolong Liu; Roza Nurieva; Lilin Ye; Qiang Tian; Xiu-Wu Bian; Chen Dong
Journal:  Nature       Date:  2019-02-27       Impact factor: 49.962

8.  Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial.

Authors:  Robert J Motzer; Brian I Rini; David F McDermott; Bruce G Redman; Timothy M Kuzel; Michael R Harrison; Ulka N Vaishampayan; Harry A Drabkin; Saby George; Theodore F Logan; Kim A Margolin; Elizabeth R Plimack; Alexandre M Lambert; Ian M Waxman; Hans J Hammers
Journal:  J Clin Oncol       Date:  2014-12-01       Impact factor: 44.544

9.  Spontaneous presence of FOXO3-specific T cells in cancer patients.

Authors:  Stine Kiaer Larsen; Shamaila Munir Ahmad; Manja Idorn; Özcan Met; Evelina Martinenaite; Inge Marie Svane; Per Thor Straten; Mads Hald Andersen
Journal:  Oncoimmunology       Date:  2014-11-14       Impact factor: 8.110

10.  The CD70-CD27 axis, a new brake in the T helper 17 cell response.

Authors:  Xiaohu Wang; Chen Dong
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.